| |
| |
|
| Insider
Information: |
Dentzer James E |
| Relationship: |
President & CEO, Direc... |
| City: |
Cranbury |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
96,952 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$364,969 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
96,952 |
|
|
| Total
Value |
$364,969 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amicus Therapeutics Inc |
FOLD |
Chief Financial Officer |
2009-10-01 |
32,075 |
|
0 |
Premium* |
|
|
Curis Inc |
CRIS |
President & CEO, Direc... |
2022-01-31 |
64,877 |
2018-01-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CRIS |
Curis Inc |
President & CEO |
• • – |
2022-01-31 |
4 |
AS |
$3.07 |
$9,499 |
D/D |
(3,094) |
64,877 |
0 |
% |
|
| CRIS |
Curis Inc |
President & CEO |
• • – |
2022-01-27 |
4 |
AS |
$3.18 |
$7,651 |
D/D |
(2,406) |
67,971 |
0 |
% |
|
| CRIS |
Curis Inc |
President & CEO |
• • – |
2021-01-26 |
4 |
AS |
$10.59 |
$32,758 |
D/D |
(3,094) |
67,268 |
0 |
% |
|
| CRIS |
Curis Inc |
President & CEO |
• • – |
2021-01-25 |
4 |
AS |
$10.96 |
$25,022 |
D/D |
(2,283) |
70,362 |
0 |
% |
|
| CRIS |
Curis Inc |
President & CEO |
• • – |
2020-01-24 |
4 |
AS |
$1.64 |
$5,076 |
D/D |
(3,094) |
42,158 |
0 |
% |
|
| CRIS |
Curis Inc |
President & CEO |
• • – |
2020-01-23 |
4 |
AS |
$1.69 |
$6,182 |
D/D |
(3,658) |
45,252 |
0 |
% |
|
| CRIS |
Curis Inc |
President & CEO |
• • – |
2019-01-24 |
4 |
AS |
$1.16 |
$3,577 |
D/D |
(3,094) |
41,639 |
0 |
- |
|
| CRIS |
Curis Inc |
President & CEO |
• • – |
2019-01-23 |
4 |
AS |
$1.09 |
$2,613 |
D/D |
(2,397) |
44,733 |
0 |
- |
|
| CRIS |
Curis Inc |
Chief Financial Officer |
• – – |
2018-01-22 |
4 |
A |
$0.00 |
$0 |
D/D |
206,250 |
212,011 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2009-10-01 |
4 |
D |
$8.75 |
$1,925 |
D/D |
(220) |
32,075 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2009-09-01 |
4 |
D |
$9.83 |
$2,163 |
D/D |
(220) |
32,295 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2009-08-01 |
4 |
D |
$11.39 |
$2,506 |
D/D |
(220) |
32,515 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2009-07-01 |
4 |
D |
$11.45 |
$2,519 |
D/D |
(220) |
32,735 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2009-06-01 |
4 |
D |
$6.64 |
$1,461 |
D/D |
(220) |
32,955 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2009-05-01 |
4 |
D |
$8.95 |
$1,969 |
D/D |
(220) |
33,175 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2009-04-01 |
4 |
D |
$9.13 |
$2,009 |
D/D |
(220) |
33,395 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2009-03-01 |
4 |
D |
$8.06 |
$1,773 |
D/D |
(220) |
33,615 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2009-02-01 |
4 |
D |
$8.69 |
$1,912 |
D/D |
(220) |
33,835 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2009-01-02 |
4 |
D |
$8.00 |
$1,760 |
D/D |
(220) |
34,055 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2008-12-01 |
4 |
D |
$7.98 |
$1,756 |
D/D |
(220) |
34,275 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2008-11-03 |
4 |
D |
$10.45 |
$2,299 |
D/D |
(220) |
34,495 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2008-10-01 |
4 |
D |
$15.10 |
$3,322 |
D/D |
(220) |
34,715 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2008-09-02 |
4 |
D |
$13.86 |
$3,049 |
D/D |
(220) |
34,935 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2008-08-01 |
4 |
D |
$15.61 |
$3,434 |
D/D |
(220) |
35,155 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2008-07-01 |
4 |
D |
$10.81 |
$2,378 |
D/D |
(220) |
35,375 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
